Open AccessPrognostic Significance of Low HER2 Expression in Patients With Metastatic Hormone Receptor-positive Breast Cancer Treated With First Line CDK4/6 Inhibitors: A Greek Multicenter Real-world Data Analysis
Author(s) -
George Douganiotis,
George Kesisis,
Efthalia Lalla,
Ippokratis Korantzis,
Ioannis Boukovinas,
Konstantinos Papazisis
Publication year - 2022
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10146
Subject(s) - medicine , metastatic breast cancer , fulvestrant , breast cancer , oncology , immunohistochemistry , cancer , hormone receptor , population , estrogen receptor , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom